[1]李　建,江　洋.光动力疗法联合糖皮质激素治疗瘢痕疙瘩疗效观察[J].新乡医学院学报,2020,37(8):783-786.[doi:10.7683/xxyxyxb.2020.08.019]
　LI Jian,JIANG Yang.Effect of photodynamic therapy combined with glucocorticoid in the treatment of keloid[J].Journal of Xinxiang Medical University,2020,37(8):783-786.[doi:10.7683/xxyxyxb.2020.08.019]
点击复制

光动力疗法联合糖皮质激素治疗瘢痕疙瘩疗效观察
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
37
期数:
2020年8
页码:
783-786
栏目:
临床研究
出版日期:
2020-08-05

文章信息/Info

Title:
Effect of photodynamic therapy combined with glucocorticoid in the treatment of keloid
作者:
李　建; 江　洋
（新乡医学院第一附属医院烧伤整形与医疗美容科，河南　卫辉　453100）
Author(s):
LI Jian; JIANG Yang
(Department of Burn-Plastic Surgery and Medical Cosmetology,the First Affiliated Hospital of Xinxiang Medical University,Weihui 453100,Henan Province,China)
关键词:
瘢痕疙瘩; 光动力疗法; 温哥华瘢痕评定量表; 北卡罗来纳大学瘢痕量表
Keywords:
keloid; photodynamic therapy; Vancouver scar scale; University of North Carolina scar scale
分类号:
R622
DOI:
10.7683/xxyxyxb.2020.08.019
文献标志码:
A
摘要:
目的　探讨光动力疗法联合糖皮质激素治疗瘢痕疙瘩的临床效果。方法　选择2017年1月至2019年1月新乡医学院第一附属医院收治的86例瘢痕疙瘩患者为研究对象，根据治疗方法将患者分为观察组和对照组，每组43例。对照组患者给予复方倍他米松注射液皮损内注射治疗，观察组患者给予光动力疗法联合复方倍他米松注射液皮损内注射；治疗2个月后评估临床疗效，并观察治疗期间患者不良反应；分别于治疗前、治疗1个疗程、治疗后2个月、治疗后1 a对2组患者瘢痕情况进行温哥华瘢痕量表（VSS）评分和北卡罗来纳大学瘢痕量表评分。结果　观察组和对照组患者治疗总有效率分别为88.37%（38/43）、55.81%（24/43），观察组患者治疗总有效率显著高于对照组（χ2=11.328，P<0.05）。观察组和对照组患者不良反应发生率分别为20.93%（9/43）、25.58%（11/43），2组患者不良反应发生率比较差异无统计学意义（χ2=0.261，P>0.05）。治疗前2组患者VSS评分、北卡罗来纳大学瘢痕量表评分比较差异无统计学意义（P>0.05），2组患者治疗1个疗程、治疗后2个月及治疗后1 a时VSS评分、北卡罗来纳大学瘢痕量表评分显著低于治疗前（P<0.05）；治疗1个疗程、治疗后2个月及治疗后1 a时，观察组患者VSS评分、北卡罗来纳大学瘢痕量表评分显著低于对照组（P<0.05）。结论　光动力疗法联合糖皮质激素皮损内注射能够显著改善瘢痕疙瘩状态，提高临床疗效，且无明显不良反应。
Abstract:
Objective　To investigate the clinical effect of photodynamic therapy combined with glucocorticoid in the treatment of keloid.Methods　A total of 86 patients with keloid admitted to the First Affiliated Hospital of Xinxiang Medical University from January 2017 to January 2019 were selected as the research subjects,and they were divided into observation group and control group according to the treatment methods,with 43 cases in each group.The patients in the control group were treated with compound betamethasone injection by subcutaneous injection,and the patients in the observation group were treated with photodynamic therapy and compound betamethasone injection by subcutaneous injection.The clinical effect was evaluated after two months of treatment,and the adverse reactions during treatment were observed.The scar condition of the patients in the two groups were evaluated by Vancouver scar scale (VSS) and University of North Carolina scar scale at the time points of before treatment,one course of treatment,two months after treatment and one year after treatment.Results　The total effective rate in the observation group and the control group was 88.37% (38/43) and 55.81% (24/43),respectively.The total effective rate in the observation group was significantly higher than that in the control group (χ2=11.328,P<0.05).The incidence of adverse reactions in the observation group and the control group was 20.93% (9/43) and 25.58% (11/43),respectively.There was no significant difference in the incidence of adverse reactions between the two groups (χ2=0.261,P>0.05).There was no significant difference in the VSS score and the North Carolina University scar scale score between the two groups before treatment (P>0.05).The scores of VSS and University of North Carolina scar scale at the time points of before treatment,one course of treatment,two months after treatment and one year after treatment were significantly lower than those before treatment in the two groups (P<0.05).The scores of VSS and University of North Carolina scar scale in the observation group were significantly lower than those in the control group at the time points of one course of treatment,two months after treatment and one year after treatment (P<0.05).Conclusion　Photodynamic therapy combined with glucocorticoid cutaneous intralesional injection can significantly improve the status of keloid,and increase the clinical effect without obvious adverse reactions.

参考文献/References:

［1］　LI Z,JIN Z.Comparative effect and safety of verapamil in keloid and hypertrophic scar treatment:a meta-analysis［J］.Clin Risk Manag,2016,12(16):1635-1641.
［2］　BUSCH K H,ALIU A,WALEZKO N,et al.Medical needling:effect on skin erythema of hypertrophic burn scars［J］.Cureus,2018,10(9):e3260-3260.
［3］　ELMELEGY N G,HEGAZY A M,SADAKA M S,et al.Electro photo biomodulation in the treatment of facial post-burn hypertrophic scars in pediatric patients［J］.Ann Burns Fire Disasters,2018,31(2):127-132.
［4］　GALE J D,JENSEN J,BERMAN G,et al.A placebo-controlled study of PF-06473871 (anti-connective tissue growth factor antisense oligonucleotide) in reducing hypertrophic skin scarring［J］.Plast Reconstr Surg Glob Open,2018,6(9):e1861-e1869.
［5］　TEJIRAM S,ZHANG J,TRAVIS T E,et al.Compression therapy affects collagen type balance in hypertrophic scar［J］.J Surg Res,2016,201(2):299-305.
［6］　BERMAN B,MADERAL A,RAPHAEL B.Keloids and hypertrophic scars:pathophysiology,classification,and treatment［J］.Dermatol Surg,2017,43(Suppl 1):S3-S18.
［7］　蔡景龙.现代瘢痕学［M］.2版.北京：人民卫生出版社，2008：189-190.
［8］　谭军，李波，李高峰，等.点阵二氧化碳激光治疗各类瘢痕的疗效评价［J］.中华损伤与修复杂志：电子版，2010，5（5）：578-582.DOI：10.3877/cma.j.issn.1673-9450.2010.05.003.
［9］　FORBES-DUCHART L,MARSHALL S,STROCK A,et al.Determination of inter-rater reliability in pediatric burn scar assessment using a modified version of the Vancouver scar scale［J］.J Burn Care Res,2007,28(3):460-467.
［10］　QU L,LIU A,ZHOU L,et al.Clinical and molecular effects on mature burn scars after treatment with a fractional CO2 laser［J］.Lasers Surg Med,2012,44(7):517-524.
［11］　方芳，程丽芳，程波.光动力学疗法对瘢痕疙瘩成纤维细胞增殖和凋亡蛋白的影响［J］.中华医学美学美容杂志，2017，23（6）：412-414.
［12］　宁金斌，冯剑.光动力法配合激素治疗对增生性瘢痕患者VSS评分改善效果及p-STAT3 Egr-1表达的影响［J］.河北医学，2018，24（1）：135-139.
［13］　湛意，肖嵘，张智炜.光动力疗法在非肿瘤性皮肤病中的应用进展［J］.中南大学学报（医学版），2018，43（12）：1380-1383.
［14］　雷颖，李石峰，喻亿玲，等.不同超脉冲二氧化碳点阵激光模式联合治疗面颈部增生性瘢痕的临床效果［J］.中华烧伤杂志，2016，32（8）：474-478.
［15］　刘秀峰，潘文东，张元文，等.点阵激光联合复方倍他米松注射液治疗增生性瘢痕20例疗效观察［J］.中国皮肤性病学杂志，2016，30（5）：527-529.
［16］　陈子翔，殷国前，潘新元，等.Egr-1、Nab2和Cav-1的表达与瘢痕增生的相关性研究［J］.中华整形外科杂志，2016，32（6）：453-457.
［17］　王晓川.光动力疗法治疗病理性瘢痕的疗效及预后分析［J］.基因组学与应用生物学，2018，37（11）：4871-4877.
［18］　田梦，叶志梅，徐晓静，等.光动力疗法联合复方倍他米松对增生性瘢痕患者负性情绪和瘢痕组织p-STAT3、Egr-1表达的影响［J］.现代生物医学进展，2019，19（21）：4036-4040.

相似文献/References:

[1]马莹莹,邹朝晖.光动力疗法对大鼠龋齿模型的防龋效果及机制[J].新乡医学院学报,2018,35(1):016.[doi:10.7683/xxyxyxb.2018.01.004]
　MA Ying-ying,ZOU Zhao-hui.Effect and mechanism of photodynamic therapy on dental caries in rats[J].Journal of Xinxiang Medical University,2018,35(8):016.[doi:10.7683/xxyxyxb.2018.01.004]
[2]李婉迪,赵振民.转化生长因子-β/Smads信号通路在病理性瘢痕形成中的作用机制研究进展[J].新乡医学院学报,2017,34(4):335.[doi:10.7683/xxyxyxb.2017.04.024]
[3]卫艳萍,谢彤阳,王廷廷,等.微RNA-133a-3p靶向调控转化生长因子-β1/Smad3对瘢痕疙瘩成纤维细胞增殖和凋亡的影响[J].新乡医学院学报,2022,39(4):330.[doi:10.7683/xxyxyxb.2022.04.006]
　WEI Yanping,XIE Tongyang,WANG Tingting,et al.Effect of microRNA-133a-3p on proliferation and apoptosis of keloid fibroblasts by targeting transforming growth factor-β1/Smad3[J].Journal of Xinxiang Medical University,2022,39(8):330.[doi:10.7683/xxyxyxb.2022.04.006]

更新日期/Last Update: 2020-08-05